Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F13JD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,220
Award facts
- Contract value 100% obligated
- $10,220.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication, with a ceiling value of $10,220.11. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The SPE2DX prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of medications, vaccines, and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order for Ozempic, a diabetes medication, exemplifies the company's role in fulfilling federal pharmaceutical needs through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F13JD?
SPE2DR26F13JD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F13JD worth?
The government has obligated $10,220 on SPE2DR26F13JD.
Is contract SPE2DR26F13JD an order under another contract?
Yes. SPE2DR26F13JD is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13JD competed?
The extent of competition for SPE2DR26F13JD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award